<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

PBMC-Humanized Models for In Vivo I/O Studies

The recent rise in cancer immunotherapy research and drug approvals is providing promising treatment options for cancer patients, as well as new opportunities for translational scientists to identify and develop new classes of immunomodulatory agent.